Sagimet Biosciences Inc. (United States) is listed on the Nasdaq and has a market capitalization of $631.81 million, with shareholders equity totaling $242.18 million.
The company employs approximately 16 people and operates in the Other sector, within the Other industry.
Over the past 12 months, Sagimet Biosciences Inc. reported $- in revenue, generating net income of $-53.32 million.
Key financial metrics include a P/E ratio of -11.85, a price-to-book (P/B) ratio of 2.61, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker SGMT.